ConforMIS, Inc. IPO Advisory
Share this IPO Profile:
Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
ConforMIS, Inc. | CFMS - NASDAQ |
$14.00-$16.00 |
$15.00 |
$18.00 | 9 million | 7/1/2015 |
J.P. Morgan, Deutsche Bank Securities |
Co-Manager(s): Wells Fargo Securities, Canaccord Genuity, Oppenheimer & Co. |
Health Care |
Filing(s): Filed 2015-05-22 Terms Added 2015-06-18
|
For IPO Boutique's "scale of 1 to 5" BUY rating on ConforMIS, Inc., and our comprehensive analysis, click "Buy Market Research".
ConforMIS, Inc. Quote & Chart - Click for current quote -
CFMS
About ConforMIS, Inc. (adapted from ConforMIS, Inc. prospectus):
They are a medical technology company that uses our proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped, which we refer to as customized, to fit each patient's unique anatomy.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "CFMS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2024 IPO Boutique. All Rights Reserved